Will a CRISPR-based therapy cure a major genetic disease by 2029?
CRISPR gene editing has advanced rapidly for treating diseases like sickle cell. This market asks whether a CRISPR or similar gene-editing therapy receives full approval and demonstrates a functional cure for a major inh...
Factor de liquidez (b) | 100.00 |
Liquidez total | ℂ0.00 |
Volumen | ℂ0.00 |
Interés abierto | 0 |
Proporción de acciones | 0 / 0 |
The market resolves to YES if at least one CRISPR therapy is approved and shows long-term curative results for a major genetic disease by Dec 31, 2029, per FDA, EMA, or peer-reviewed studies. Resolves to NO otherwise.
No se encontraron cambios en los campos.
Historial de probabilidades
No hay suficientes datos para mostrar el gráfico.
Actividad reciente
No se encontraron operaciones.
Mayores tenedores de SÍ
No se encontraron tenedores.
Mayores tenedores de NO
No se encontraron tenedores.
Preguntas frecuentes del mercado
Este mercado se cerrará para operar el 1 de enero de 2030, 01:00.
Se resolverá usando estas reglas: The market resolves to YES if at least one CRISPR therapy is approved and shows long-term curative results for a major genetic disease by Dec 31, 2029, per FDA, EMA, or peer-reviewed studies. Resolves to NO otherwise.
Este es un mercado público, así que cualquier persona en KrowdCall puede verlo y participar antes de que cierre la operativa.
Este mercado pertenece a la categoría Ciencia.
El estado actual de este mercado es Abierto.